Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Suzuken Co ( (JP:9987) ) just unveiled an announcement.
Suzuken Co., Ltd. announced the results of its share repurchase program for July 2025, acquiring 584,000 common shares for approximately ¥3.15 billion through market purchases on the Tokyo Stock Exchange. This is part of a larger initiative to repurchase up to 5.2 million shares by March 2026, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen5800.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical industry, primarily focusing on the distribution of pharmaceutical products and medical devices. The company is listed on the Prime Markets of the Tokyo and Nagoya Stock Exchanges, as well as the Sapporo Securities Exchange.
Average Trading Volume: 203,930
Technical Sentiment Signal: Buy
Current Market Cap: Yen320.3B
See more insights into 9987 stock on TipRanks’ Stock Analysis page.